BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 3522223)

  • 1. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid.
    Salter RD; Cresswell P
    EMBO J; 1986 May; 5(5):943-9. PubMed ID: 3522223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of class I histocompatibility antigens on human T-B lymphoblast hybrids.
    Howell DN; Kostyu DD; Ting JP; Cresswell P
    Somat Cell Mol Genet; 1984 May; 10(3):217-24. PubMed ID: 6609440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.
    Salter RD; Howell DN; Cresswell P
    Immunogenetics; 1985; 21(3):235-46. PubMed ID: 3872841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The transport of class I major histocompatibility complex antigens is determined by sequences in the alpha 1 and alpha 2 protein domains.
    Alexander J; Payne JA; Shigekawa B; Frelinger JA; Cresswell P
    Immunogenetics; 1990; 31(3):169-78. PubMed ID: 2318516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Isolation of a human major histocompatibility complex class I gene encoding a nonubiquitous molecule expressed on activated lymphocytes.
    Paul P; Fauchet R; Boscher MY; Sayagh B; Masset M; Medrignac G; Dausset J; Cohen D
    Proc Natl Acad Sci U S A; 1987 May; 84(9):2872-6. PubMed ID: 3033667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
    Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
    Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide-induced stabilization and intracellular localization of empty HLA class I complexes.
    Baas EJ; van Santen HM; Kleijmeer MJ; Geuze HJ; Peters PJ; Ploegh HL
    J Exp Med; 1992 Jul; 176(1):147-56. PubMed ID: 1613456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential transport requirements of HLA and H-2 class I glycoproteins.
    Alexander J; Payne JA; Murray R; Frelinger JA; Cresswell P
    Immunogenetics; 1989; 29(6):380-8. PubMed ID: 2731965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel allele-specific, post-translational reduction in HLA class I surface expression in a mutant human B cell line.
    Greenwood R; Shimizu Y; Sekhon GS; DeMars R
    J Immunol; 1994 Dec; 153(12):5525-36. PubMed ID: 7989754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The synthesis and expression of HLA-A and -B antigens in Xenopus laevis oocytes.
    Kinnon C; Owen MJ
    Mol Immunol; 1986 May; 23(5):525-32. PubMed ID: 3092030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antigen-processing mutant T2 suggests a role for MHC-linked genes in class II antigen presentation.
    Riberdy JM; Cresswell P
    J Immunol; 1992 Apr; 148(8):2586-90. PubMed ID: 1373173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular definition of a polymorphic antigen (LA45) of free HLA-A and -B heavy chains found on the surfaces of activated B and T cells.
    Madrigal JA; Belich MP; Benjamin RJ; Little AM; Hildebrand WH; Mann DL; Parham P
    J Exp Med; 1991 Nov; 174(5):1085-95. PubMed ID: 1940790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitation of differential expression of HLA-A,B,C antigens on choriocarcinoma cell lines by messenger RNA for HLA heavy chain but not by beta 2-microglobulin.
    Kawata M; Sizer K; Sekiya S; Parnes JR; Herzenberg LA
    Cancer Res; 1984 Sep; 44(9):4011-6. PubMed ID: 6204750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition by xenogeneic cytotoxic T lymphocytes of cells expressing HLA-A2 or HLA-B7 after DNA-mediated gene transfer.
    Herman A; Parham P; Weissman SM; Engelhard VH
    Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5056-60. PubMed ID: 6192447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphatase inhibitors block in vivo binding of peptides to class I major histocompatibility complex molecules.
    Tector M; Zhang Q; Salter RD
    J Biol Chem; 1994 Oct; 269(41):25816-22. PubMed ID: 7523393
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional control of HLA-A,B,C antigen in human placental cytotrophoblast isolated using trophoblast- and HLA-specific monoclonal antibodies and the fluorescence-activated cell sorter.
    Kawata M; Parnes JR; Herzenberg LA
    J Exp Med; 1984 Sep; 160(3):633-51. PubMed ID: 6206184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human class I histocompatibility antigens (HLA-A,B,C). A small proportion only is phosphorylated.
    Loube SR; Owen MJ; Crumpton MJ
    Biochem J; 1983 Jan; 210(1):79-87. PubMed ID: 6303316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides.
    Wei ML; Cresswell P
    Nature; 1992 Apr; 356(6368):443-6. PubMed ID: 1557127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer.
    Doyle A; Martin WJ; Funa K; Gazdar A; Carney D; Martin SE; Linnoila I; Cuttitta F; Mulshine J; Bunn P
    J Exp Med; 1985 May; 161(5):1135-51. PubMed ID: 2580935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens.
    Henne C; Schwenk F; Koch N; Möller P
    Immunology; 1995 Feb; 84(2):177-82. PubMed ID: 7750992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.